Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Daily Archives: July 5, 2022

  1. Home>
  2. 2022>
  3. July>
  4. 5
October 8: Golf for Phelan-McDermid Syndrome
Source: Pixabay.com

October 8: Golf for Phelan-McDermid Syndrome

  • Post author:Jessica Lynn
  • Post published:July 5, 2022
  • Post category:22q13 Deletion Syndrome/Phelan-McDermid syndrome

  In 2019, Courtney and Michael Henderson welcomed the newest member of their family – their son Luke. They were thrilled at this new addition, who they say is one…

Continue Reading October 8: Golf for Phelan-McDermid Syndrome
Study: Anlotinib as a Monotherapy for Esophageal Cancer
source: pixabay.com

Study: Anlotinib as a Monotherapy for Esophageal Cancer

  • Post author:Rose Duesterwald
  • Post published:July 5, 2022
  • Post category:Esophageal Cancer

  The most common gastrointestinal tumors in the world are esophageal cancers. A recent article in DovePress reports that the malignancy is also the eighth most common worldwide. In China…

Continue Reading Study: Anlotinib as a Monotherapy for Esophageal Cancer
ICYMI: Midodrine Increases PAH Therapy Tolerability
Photo by Paweł Czerwiński on Unsplash

ICYMI: Midodrine Increases PAH Therapy Tolerability

  • Post author:Jessica Lynn
  • Post published:July 5, 2022
  • Post category:pulmonary arterial hypertension

  From May 13-18, 2022, the American Thoracic Society (ATS) held its Annual Meeting, where researchers and stakeholders discussed research, patient care, and public health trends within the fields of…

Continue Reading ICYMI: Midodrine Increases PAH Therapy Tolerability

Following a Stroke, a Man is Diagnosed with IMNM

  • Post author:Alyssa Stevens
  • Post published:July 5, 2022
  • Post category:Rare Disease

  According to a recent article, a man who developed terrifying symptoms following a stroke was found to have statin-associated immune-mediated necrotizing myopathy.   Unexpected Symptoms After Stroke When her…

Continue Reading Following a Stroke, a Man is Diagnosed with IMNM
PI3K Inhibitor Umbralisib for Marginal Zone Lymphoma Has FDA Approval Withdrawn
https://unsplash.com/photos/8ztH-7lj8ag

PI3K Inhibitor Umbralisib for Marginal Zone Lymphoma Has FDA Approval Withdrawn

  • Post author:Alyssa Stevens
  • Post published:July 5, 2022
  • Post category:Marginal Zone Lymphoma

  According to a recent article, the PI3K inhibitor umbralisib used to treat marginal zone lymphoma has had its approval withdrawn by the FDA.   Marginal Zone Lymphoma (MZL) Marginal…

Continue Reading PI3K Inhibitor Umbralisib for Marginal Zone Lymphoma Has FDA Approval Withdrawn

Featured


Picture of Family


Metastatic Breast Cancer: Navigating Grief


Picture of Ralph Family walking


Rethinking What It Means to Live With Acromegaly


Illustration of mentor program members


The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info